

Trader Mindset
Michael Martin
Michael Martin discusses trader psychology and emotional intelligence.
Episodes
Mentioned books

Sep 10, 2018 • 8min
How to use volatility to reduce your watch list
If the instrument you're looking at has a daily volatility measurement that is greater in dollars than you are willing to risk, you must pass on the trade.

Sep 7, 2018 • 10min
How to keep your trading costs low
Money you don't spend when you're starting out is money that you don't need to earn. And that's important when you don't fully understand what you're doing.

Sep 6, 2018 • 15min
What I would tell my 20 year old self
The trading world has changed since I began, but the tenets of good trading are still in tact. Here's how I would counsel myself at the beginning of my career based upon what I know now and the experiences I've had - both good and bad.

Sep 5, 2018 • 8min
Why you can't be everything to everybody
Focus on one style of trading. Build a system for client communications also. Else, your business is going to run you.

Aug 16, 2018 • 1h 18min
How to Trade Earnings Season with Mike Katz

Aug 14, 2018 • 10min
How to interpret insider selling

Aug 10, 2018 • 44min
Sign of the "High" Times with Matt Dula
Cannabis Green Book partners with Equifax and Matt and Michael revisit the High Times IPO.

Aug 6, 2018 • 57min
Peter Borish Booms and Busts in Global Macro Trading
Michael Martin and Peter Borish discuss the current environment and when it looked like this before. We also speak about what inspired him to develop his analog model that anticipated the market crash in 1987. Peter is on the faculty at MartinKronicle and also joins the "live" Mastermind to answer our students questions.

Aug 1, 2018 • 30min
How the VIX can play a role in your portfolio
Hari Krishnan returns to the show to discuss how the VIX can play a role in portfolio diversification, not unlike Managed Futures. [Sorry about some of the audio. Hari's schedule is very tight and he was overseas at the time of our recording. No matter how many times we hung up and retried getting a better connection, nothing worked.]

Jul 31, 2018 • 28min
Matt Dula on the DEA and FDA Drug Approval Process
Shareholders of GWPH need two approvals in order for their investment to pay off, one of which they have - the FDA approval. Trickier to understand is the DEA approval which needs to happen by the end of September or 3 months after the FDA approval.


